IDH1 Mutant AML Is Susceptible to Targeting De Novo Lipid Synthesis Independent of 2-Hydroxyglutarate and Has a Distinct Metabolic Profile from IDH2 Mutant AML

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
• 作者

  Thomas Daniel; Nakauchi Yusuke; Wu Manhong; Zheng Ming; Sinha Subarna; Dill David; Peltz Gary; Majeti Ravindra;

  展开▼
• 作者单位

  Stanford Univ Div Hematol Dept Med Stanford CA 94305 USA;

  Stanford Univ Inst Stem Cell Biol &

  Regenerat Med Stanford CA 94305 USA;

  Stanford Univ Anesthesia Stanford CA 94305 USA;

  Stanford Univ Anesthesia Stanford CA 94305 USA;

  Stanford Res Inst Menlo Pk CA USA;

  Stanford Univ Comp Sci Stanford CA 94305 USA;

  Stanford Univ Anesthesia Stanford CA 94305 USA;

  Stanford Univ Inst Stem Cell Biol &

  Regenerat Med Stanford CA 94305 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词